Robert Perkins is a seasoned medical affairs executive with extensive leadership experience in the pharmaceutical industry. Currently serving as Vice President for Renal and Cardiovascular at Bayer, Perkins manages a large team and a significant budget to support innovative treatments for diabetic kidney disease and heart failure. Previously, at Novartis, Perkins led the strategic pre-launch efforts for Iptacopan, ensuring effective initiatives for rare glomerular disease diagnoses. During a tenure at AstraZeneca, Perkins directed medical support for a groundbreaking HIF-PH Inhibitor. With an AB in English Literature from Harvard University, an MD from the University of Pittsburgh School of Medicine, and an MPH in Epidemiology from Johns Hopkins University, Perkins combines a strong academic background with expertise in medical strategy and program development.
This person is not in the org chart
This person is not in any teams
This person is not in any offices